None listed
Conditions
Interventions
Intervention1: LR 82 milk powder: 50 gms (equivalent to 2.8 ug B12) twice a day for 8 weeks to be taken orally
Total dose 313.6 ug vit B12 in 56 days
Control Intervention1: Cyano cobalamin: 2.8 ug cy
Sponsors
Department of Biotechnology
Eligibility
Inclusion criteria
Inclusion criteria: Healthy Participants between the age of 28-55 yrs
Exclusion criteria
Exclusion criteria: Participants with more than 200 pg/mL plasma vitamin B12 Participants taking drugs known to influence vitamin B12 absorption (metformin, methotrexate) Cancer patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in vitamin B12 statusTimepoint: 4 weeks supplementation4 | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in plasma homocysteine and methylmalonic acid levelsTimepoint: at the end of 4 weeeks | — |
Countries
India
Contacts
Public ContactDr Sadanand S Naik
Deenanath Mangeshkar Hopsital and Res Centre
Outcome results
None listed